Clinical Trial Update: A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing once-weekly Somapacitan to daily Norditropin in children with growth disorders (SGA, Turner syndrome, Noonan syndrome, and idiopathic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature
• Noonan Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Norditropin (somatropin)
• Somapacitan (somapacitan)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: SGA, Turner Syndrome, Noonan Syndrome, ISS | Phase 3 | Status: ACTIVE_NOT_RECRUITING